When did ADMA Biologics report Q4 2024 earnings?

ADMA Biologics (ADMA) reported Q4 2024 earnings on March 3, 2025 after market close.

What were ADMA Biologics's Q4 2024 revenue and EPS?

ADMA Biologics reported revenue of $117.5M and eps of $0.14 for Q4 2024.

Did ADMA Biologics beat estimates in Q4 2024?

Revenue beat the consensus estimate of $108.7M by $8.9M. EPS missed the consensus estimate of $0.15 by $0.01.

Where can I find ADMA Biologics's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001140361-25-009257) directly on SEC EDGAR. The filing index links above go to sec.gov.

ADMA Biologics ADMA Q4 2024 Annual earnings

Reported March 3, 2025 · After market close

Revenue$117.5MBeat by $8.9M

EPS$0.14Miss by $0.01

Revenue estimate$108.7M

EPS estimate$0.15

Next report

Aug 5, 2026 (In 1 week)

Revenue estimate$125.3M

EPS estimate$0.16

Financials

Q4 2024

Income statement

See full

Revenue$117.5M+59.1%

Gross profit$63.3M+104%

Operating income$38.3M+169%

Net income$111.9M+734%

EPS (diluted)$0.46+675%

Balance sheet

See full

Cash & equivalents$103.1M+101%

Total debt$82.1M+659%

Total equity$349.0M+158%

Total assets$488.7M+48.5%

Cash flow

See full

Operating cash flow$50.2M+185%

CapEx$2.8M+130%

Free cash flow$47.5M+189%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$4.05B+297%

Enterprise value$4.03B+311%

P/E20.5×—

P/S9.5×+5.6×

Profitability

See full

Gross margin51.5%+17.0pp

Operating margin32.6%+24.2pp

Net margin46.4%+38.9pp

FCF margin25.9%+24.3pp

Returns & leverage

See full

Return on equity81.6%+68.4pp

Debt / equity0.2×+0.2×

Current ratio6×+0.8×

Segments

By product

See full

ASCENIV$59.9M+159%

BIVIGAM$35.6M+1.5%

Intermediates And Other$8.5M—

By segment

See full

ADMA Bio Manufacturing$111.9M+51.3%

Plasma Collection Centers$5.7M+16,254%

By geography

See full

US$114.7M—

Versus estimates

Revenue

Q1 2026$114.5MMiss by $25.5M Q4 2025$139.2MMiss by $437.0K Q3 2025$134.2MMiss by $5.6M Q2 2025$122.0MMiss by $8.3M Q1 2025$114.8MMiss by $7.0M

Q4 2024$117.5MBeat by $8.9M

Diluted EPS

Q1 2026$0.19Miss by $0.00 Q4 2025$0.20Beat by $0.02 Q3 2025$0.16In line Q2 2025$0.15Beat by $0.01 Q1 2025$0.14Miss by $0.02

Q4 2024$0.14Miss by $0.01

Ask the moment ADMA Biologics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did ADMA Biologics report Q4 2024 earnings?: ADMA Biologics (ADMA) reported Q4 2024 earnings on March 3, 2025 after market close.
What were ADMA Biologics's Q4 2024 revenue and EPS?: ADMA Biologics reported revenue of $117.5M and eps of $0.14 for Q4 2024.
Did ADMA Biologics beat estimates in Q4 2024?: Revenue beat the consensus estimate of $108.7M by $8.9M. EPS missed the consensus estimate of $0.15 by $0.01.
Where can I find ADMA Biologics's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001140361-25-009257) directly on SEC EDGAR. The filing index links above go to sec.gov.